U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06862778) titled 'Clinical Diagnosis of Diabetes Using Surface-enhanced Raman Spectroscopy Liquid Biopsy and Machine Learning' on March 01.
Brief Summary: This project aims to adapt the gold nanoparticle-based surface-enhanced Raman spectroscopy (SERS) technology to clinical application. In this exploratory study, a measurement protocol will be established to investigate whether SERS (combined with multivariate data analysis or machine learning algorithms) allows the diagnosis of patients with diabetes.
Study Start Date: Feb. 02, 2024
Study Type: INTERVENTIONAL
Condition:
Diabetes
Intervention:
DIAGNOSTIC_TEST: SERS
Spectroscopic assessment of...